Metagenomi director Laurence Reid acquires common shares worth $23,403.95

PUBT · 1d ago
Metagenomi director Laurence Reid acquires common shares worth $23,403.95
  • Director Laurence Reid bought 20,000 Metagenomi Therapeutics common shares in open-market purchases priced around $1.17-$1.18.
  • Directly held stake rose to 20,000 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metagenomi Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-389550), on September 11, 2026, and is solely responsible for the information contained therein.